Mirati: Q4 Earnings Snapshot

SAN DIEGO (AP) — SAN DIEGO (AP) — Mirati Therapeutics Inc. (MRTX) on Tuesday reported a loss of $202.5 million in its fourth quarter.

On a per-share basis, the San Diego-based company said it had a loss of $3.51.

The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $3.74 per share.

The biopharmaceutical company posted revenue of $934,000 in the period, missing Street forecasts. Six analysts surveyed by Zacks expected $3.8 million.

For the year, the company reported that its loss widened to $740.9 million, or $13.18 per share. Revenue was reported as $12.4 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRTX at https://www.zacks.com/ap/MRTX

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up